Appropriateness of newborn screening for [alpha]1-antitrypsin deficiency

https://phgkb.cdc.gov/GAPPKB/phgHome.do;jsessionid=D2ED74AB0BA407863F04017ADD7B5E6A?Mysubmit=init&query=hepatitis&action=search&Mysubmit=Search

From Guideline Database

This database contains updated guidelines, policies and recommendations on genomic research and practice, as provided by professional organizations, federal advisory groups, expert panels and policy groups.

---

• Appropriateness of newborn screening for [alpha]1-antitrypsin deficiency.  
  Published 2014 (Alpha-1 Foundation) (Expert panel)
• Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for IFNL3 (IL28B) genotype and PEG interferon-[alpha]-based regimens.  
  Published 2014 (Clinical Pharmacogenetics Implementation Consortium (CPIC))
• Appropriateness of newborn screening for [alpha]1-antitrypsin deficiency.  
  Published 2014 (Alpha-1 Foundation - Workshop Attendees)
• Appropriateness of newborn screening for á1-antitrypsin deficiency.  
  Published 2014 (Alpha-1 Foundation)

more